title: Modification in body weight associated with antiepileptic drugs.
abstract: Antiepileptic drugs (AED) may cause body weight changes.
  
  
  OBJECTIVE
  To evaluate the dietary habits and body weight associated with AED in epileptic patients.
  
  
  METHODS
  Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months.
  
  
  RESULTS
  It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12).
  
  
  CONCLUSIONS
  The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.
authors.affiliation: Department of Neurology, University of Campinas, SP, Brazil.
authors.forename: Camilla N De
authors.initials: CN
authors.lastname: Gaspari
authors.forename: Carlos A M
authors.initials: CA
authors.lastname: Guerreiro
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid